Literature DB >> 15638232

The role of endoscopy in inflammatory bowel disease.

M Daperno1, R Sostegni, A Lavagna, L Crocellà, E Ercole, C Rigazio, R Rocca, A Pera.   

Abstract

Endoscopy is an essential tool for diagnosis, management and prognostic evaluation of inflammatory bowel disease. However dyscomfort, potential risks and costs associated to endoscopic examinations should contribute to the narrowing of indications to those cases in which the result of endoscopy is essential to determine a variation in the management strategy. Ileocolonoscopy performed by an expert endoscopist allows accurate diagnosis of Crohn's disease or ulcerative colitis in up to almost 90% of cases. Colonoscopy has a prognostic role during a severe flare of disease (the occurrence of severe endoscopic lesions have a negative prognostic value with significantly higher risk not to respond to medical treatment) both in ulcerative colitis and in Crohn's disease; moreover in Crohn's disease the evaluation of recurrent lesions at anastomosis after curative surgery has a strong prognostic role (endoscopic recurrence closely correlates with clinical/surgical recurrence) and preliminary data suggest that mucosal healing assessed with endoscopy after biologic treatments could be associated with a better prognosis. Finally colonoscopy is essential for cancer surveillance during the long-term follow-up. Furthermore there are new endoscopic techniques under evaluation in inflammatory bowel disease, like wireless capsule endoscopy or double balloon enteroscopy for the imaging of small bowel, or endoscopic ultrasound for evaluation of strictures or of perianal disease. Finally some operative techniques like balloon dilation could possibly be employed more frequently in the future in the management of Crohn's disease. Future perspectives in endoscopy for IBD are chromoendoscopy and newer endoscopic imaging techniques, possibly leading to an "in-vivo histology".

Entities:  

Mesh:

Year:  2004        PMID: 15638232

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  Colonoscopy in rats: An endoscopic, histological and tomographic study.

Authors:  Ramon Bartolí; Jaume Boix; Gemma Odena; Napoleón D De la Ossa; Vicente Moreno de Vega; Vicente Lorenzo-Zúñiga
Journal:  World J Gastrointest Endosc       Date:  2013-05-16

2.  Faecal biomarkers for screening small bowel inflammation in patients with Crohn's disease: a prospective study.

Authors:  Takahiro Shimoyama; Takayuki Yamamoto; Satoru Umegae; Koichi Matsumoto
Journal:  Therap Adv Gastroenterol       Date:  2017-07-04       Impact factor: 4.409

Review 3.  THE IMPORTANCE OF COLONOSCOPY IN INFLAMMATORY BOWEL DISEASES.

Authors:  Márcio Alexandre Terra Passos; Fernanda Correa Chaves; Nilson Chaves-Junior
Journal:  Arq Bras Cir Dig       Date:  2018-07-02

4.  The establishment of a regression model from four modes of ultrasound to predict the activity of Crohn's disease.

Authors:  Jigang Jing; Yuting Wu; Hu Zhang; Yan Zhang; Jingxi Mu; Yan Luo; Hua Zhuang
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

5.  Fermented herbal formula KIOM-MA-128 protects against acute colitis induced by dextran sodium sulfate in mice.

Authors:  Dong-Gun Kim; Mi-Ra Lee; Jae-Myung Yoo; Kwang-Il Park; Jin-Yeul Ma
Journal:  BMC Complement Altern Med       Date:  2017-07-05       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.